Search Within

Heiko Schoder

  1. "Survivorship Research"
Formats
  1. Journal Article (76)
  2. Meeting Abstract (66)
  3. Research Letter (3)
  4. Conference Paper (1)
  5. Editorial (1)
Groups
  1. Molecular Imaging and Therapy Service (147)
  2. Radiology, Department of (147)
  3. Survivorship Research (147)
  4. Department of Medicine (122)
  5. Radiation Oncology, Department of (86)
  6. Center for Hematologic Malignancies (81)

More Groups

People
  1. Joachim Yahalom (50)
  2. Andrew Zelenetz (48)
  3. Maria Palomba (48)
  4. Paul Hamlin (46)
  5. Alison Moskowitz (45)
  6. Anita Kumar (43)

More People

Years
  1. 2025 (5)
  2. 2024 (13)
  3. 2023 (18)
  4. 2022 (9)
  5. 2021 (16)
  6. 2020 (12)

More Years

Publications
  1. Blood (29)
  2. Journal of Clinical Oncology (21)
  3. International Journal of Radiation Oncology, Biology, Physics (18)
  4. Journal of Nuclear Medicine (10)
  5. Hematological Oncology (9)
  6. Cancer (4)

More Publications

Publishers
  1. American Society of Hematology (31)
  2. Elsevier Inc. (22)
  3. American Society of Clinical Oncology (21)
  4. Wiley Blackwell (13)
  5. Society of Nuclear Medicine (10)
  6. Springer (9)

More Publishers

Results (147)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy
    Journal Article

    Estilo, C. L.; Van Poznak, C. H.; Williams, T.; Bohle, G. C.; Lwin, P. T.; Zhou, Q.; Riedel, E. R.; Carlson, D. L.; Schoder, H.; Farooki, A.; more...
    The Oncologist (2008)

    Fulltext@MSK | Save
  • (18)FDG-PET with CT scan co-registration for radiation treatment planning of lymphoma patients
    Meeting Abstract

    Terezakis, S. A.; Hunt, M. A.; Schmidtlein, C. R.; Gonen, M.; Kirov, A. S.; Gonzales, A. M.; Schoder, H.; Yahalom, J.
    International Journal of Radiation Oncology, Biology, Physics (2007)

    Fulltext@MSK | Save
  • Would patient selection based on both calcitonin blood level and doubling time improve (18)F-FDG PET sensitivity in restaging of medullary thyroid cancer? - Reply
    Journal Article

    Schoder, H.; Tuttle, R. M.
    Journal of Nuclear Medicine (2007)

    Fulltext@MSK | Save
  • Diagnostic accuracy of 18F-FDG PET in restaging patients with medullary thyroid carcinoma and elevated calcitonin levels
    Journal Article

    Ong, S. C.; Schoder, H.; Patel, S. G.; Tabangay Lim, I. M.; Doddamane, I.; Gonen, M.; Shaha, A. R.; Tuttle, R. M.; Shah, J. P.; Larson, S. M.
    Journal of Nuclear Medicine (2007)

    Fulltext@MSK | Save
  • PET for staging in rhabdomyosarcoma: An evaluation of PET as an adjunct to current staging tools
    Journal Article

    Klem, M. L.; Grewal, R. K.; Wexler, L. H.; Schoder, H.; Meyers, P. A.; Wolden, S. L.
    Journal of Pediatric Hematology/Oncology (2007)

    Fulltext@MSK | Save
  • FOG-PET for staging of rhabdomyosarcoma
    Meeting Abstract

    Klem, M. L.; Grewal, R.; Wexler, L. H.; Schoder, H.; Meyers, P. A.; Wolden, S. L.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Diagnostic and prognostic value of [18F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma
    Journal Article

    Wong, R. J.; Lin, D. T.; Schòˆder, H.; Patel, S. G.; Gonen, M.; Wolden, S.; Pfister, D. G.; Shah, J. P.; Larson, S. M.; Kraus, D. H.
    Journal of Clinical Oncology (2002)

    Fulltext@MSK | Save